产品名称: | Cryptococcus neoformans (Sanfelice) Vuillemin |
---|---|
商品货号: | TS134963 |
Deposited As: | Cryptococcus neoformans (Sanfelice) Vuillemin, anamorph |
Strain Designations: | C21F3 |
Alternate State: | Filobasidiella neoformans Kwon-Chung |
Application: | resistant to rapamycin resistant to tacrolimus FK-506, FK506 sensitive to cyclosporin A S-7481/F-1 Emerging infectious disease research Biomedical Research and Development Material |
Biosafety Level: | 2
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
Product Format: | frozen |
Type Strain: | no |
Genotype: | MATalpha frr1-3
Ref![]() ![]() |
Preceptrol®: | no |
Mating Type: | alpha
Ref![]() ![]() |
Medium: | ATCC® Medium 1245: YEPD |
Growth Conditions: | Temperature: 25.0°C |
Name of Depositor: | J Heitman |
Special Collection: | NCRR Contract |
References: | Odom A, et al. Calcineurin is required for virulence of Cryptococcus neoformans. EMBO J. 16: 2576-2589, 1997. PubMed: 9184205 Arndt C, et al. Secretion of FK506/FK520 and rapamycin by Streptomyces inhibits the growth of competing Saccharomyces cerevisiae and Cryptococcus neoformans. Microbiology 145: 1989-2000, 1999. PubMed: 10463165 Arndt C, et al. Secretion of FK506/FK520 and rapamycin by Streptomyces inhibits the growth of competing Saccharomyces cerevisiae and Cryptococcus neoformans. Microbiology 145: 1989-2000, 1999. PubMed: 10463165 Arndt C, et al. Secretion of FK506/FK520 and rapamycin by Streptomyces inhibits the growth of competing Saccharomyces cerevisiae and Cryptococcus neoformans. Microbiology 145: 1989-2000, 1999. PubMed: 10463165 |